Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05526300
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2022-08-31
Brief Title:
Intelligent Hypertension Intervention Study
Sponsor:
Shanghai Tong Ren Hospital
Organization:
Shanghai Tong Ren Hospital
Study Overview
Official Title:
Randomized Study of Antihypertensive Intervention by Intelligent Hypertension Management System
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To explore whether the application of intelligent hypertension management system can effectively reduce blood pressure in hypertensive patients A total of 320 eligible subjects will be recruited and randomization to two groups The standard care group n160 will receive conventional hypertension treatment with baseline data collectedWearable blood pressure monitoring device management group intervention group n160 will receive blood pressure monitoring remotely everyday and antihypertension medication treatment Primary outcome is Net change in systolic blood pressure from baseline to 3 months follow-up Secondary outcomes include Net change in diastolic blood pressure hypertension control ratio BP 14090 mmHg
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None